Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT01928576 |
| Title | Phase II Anti-PD1 Epigenetic Priming Study in NSCLC. |
| Acronym | NA_00084192 |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Sidney Kimmel Comprehensive Cancer Center |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Southern California | Los Angeles | California | 90033 | United States | Details | |
| Sibley Memorial Hospital | Washington | District of Columbia | 20016 | United States | Details | |
| Julie Brahmer, MD | Baltimore | Maryland | 21224 | United States | Details | |
| Julie Brahmer, MD | Baltimore | Maryland | 21287 | United States | Details | |
| UPMC Cancer Center- Hillman Cancer Center | Pittsburgh | Pennsylvania | 15213 | United States | Details |